John C. Bell spends much of his time researching Oncolytic virus, Virology, Virus, Cancer cell and Cancer. The study incorporates disciplines such as Ex vivo, In vivo and Viral replication in addition to Oncolytic virus. His studies in Virology integrate themes in fields like Vaccinia and Systemic administration.
His Cancer cell research focuses on subjects like Transgene, which are linked to Hepatitis B virus, Antibody, Granulocyte and Tumor-Associated Vasculature. The various areas that John C. Bell examines in his Cancer study include Thymidine kinase and Immune system. His Cancer research research is multidisciplinary, incorporating perspectives in Tumor necrosis factor alpha, Cytotoxic T cell, Blockade and Immunotherapy.
John C. Bell mainly investigates Oncolytic virus, Virology, Virus, Cancer research and Cancer. His Oncolytic virus research focuses on Vesicular stomatitis virus and how it relates to Apoptosis. John C. Bell has included themes like Cell and In vivo in his Virology study.
He combines subjects such as Ex vivo, Antibody and Cell culture with his study of Virus. His research investigates the link between Cancer research and topics such as Immunotherapy that cross with problems in Antigen and T cell. Cancer is a subfield of Internal medicine that he studies.
John C. Bell mainly focuses on Oncolytic virus, Cancer research, Virus, Immunotherapy and Immune system. In the field of Cancer and Virology John C. Bell studies Oncolytic virus. His research in Cancer research intersects with topics in Cancer cell, Immune checkpoint, Blockade and Breast cancer.
The Virus study combines topics in areas such as Interferon, Vaccinia, Viral vector, Vaccination and Antibody. His biological study spans a wide range of topics, including Cytotoxic T cell, Oncology and T cell. His Immune system research incorporates elements of Transgene and Adenocarcinoma.
His primary areas of study are Oncolytic virus, Cancer research, Immunotherapy, Immune system and Cancer immunotherapy. Research on Immunology and Virus is a part of his Oncolytic virus study. His work deals with themes such as Cancer cell, Blockade, Vesicular stomatitis virus and Drug, which intersect with Cancer research.
John C. Bell works mostly in the field of Vesicular stomatitis virus, limiting it down to topics relating to Apoptosis and, in certain cases, Virology. His Immunotherapy research incorporates themes from Cytotoxic T cell and Antigen. Within one scientific family, he focuses on topics pertaining to Tumor microenvironment under Cancer immunotherapy, and may sometimes address concerns connected to Antitumor activity, Disease prognosis, Immune Modulators and Cell therapy.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
An Integrated Stress Response Regulates Amino Acid Metabolism and Resistance to Oxidative Stress
Heather P. Harding;Yuhong Zhang;Huiquing Zeng;Isabel Novoa.
Molecular Cell (2003)
Regulation of cell adhesion and anchorage-dependent growth by a new β1-integrin-linked protein kinase
Gregory E. Hannigan;Chungyee Leung-Hagesteijn;Linda Fitz-Gibbon;Marc G. Coppolino;Marc G. Coppolino.
Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus.
David F. Stojdl;Brian Lichty;Shane Knowles;Ricardo Marius.
Nature Medicine (2000)
VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents
David F Stojdl;Brian D Lichty;Benjamin R tenOever;Jennifer M Paterson.
Cancer Cell (2003)
ER stress‐regulated translation increases tolerance to extreme hypoxia and promotes tumor growth
Meixia Bi;Christine Naczki;Marianne Koritzinsky;Diane Fels.
The EMBO Journal (2005)
The Clk/Sty protein kinase phosphorylates SR splicing factors and regulates their intranuclear distribution.
Karen Colwill;Tony Pawson;Brenda Andrews;Jayendra Prasad.
The EMBO Journal (1996)
Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer
Jeong Heo;Tony Reid;Leyo Ruo;Caroline J. Breitbach.
Nature Medicine (2013)
Recent progress in the battle between oncolytic viruses and tumours.
Kelley A. Parato;Donna Senger;Peter A. J. Forsyth;John C. Bell.
Nature Reviews Cancer (2005)
Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans
Caroline J. Breitbach;James Burke;Derek Jonker;Derek Jonker;Joe Stephenson.
Going viral with cancer immunotherapy
Brian D. Lichty;Caroline J. Breitbach;David F. Stojdl;John C. Bell;John C. Bell.
Nature Reviews Cancer (2014)
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: